Bazedoxifene D4
| Product Name | Bazedoxifene D4 |
|---|---|
| Alternate Names | Bazedoxifene Stable Isotopes, Stable Isotopes of Bazedoxifene |
| CAT No. | CS-T-48589 |
| CAS No. | 1133695-49-4 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | Not Available |
| Mol. For. | C30H30D4N2O3 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Bazedoxifene |
| Smileys | CC1=C(C2=CC=C(O)C=C2)N(C3=CC=C(O)C=C31)CC4=CC=C(OC([2H])([2H])C([2H])([2H])N5CCCCCC5)C=C4 |
| Canonical Smiles | CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O.CC(=O)O |
| InchIKey | OMZAMQFQZMUNTP-ZQAHQZODSA-N |
| Inchl | InChI=1S/C30H34N2O3.C2H4O2/c1-22-28-20-26(34)12-15-29(28)32(30(22)24-8-10-25(33)11-9-24)21-23-6-13-27(14-7-23)35-19-18-31-16-4-2-3-5-17-31;1-2(3)4/h6-15,20,33-34H,2-5,16-19,21H2,1H3;1H3,(H,3,4)/i18D2,19D2; |
| IUPAC | acetic acid;1-[[4-[2-(azepan-1-yl)-1,1,2,2-tetradeuterioethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Bazedoxifene D4 is a selective estrogen receptor modulator (SERM) that is used in the treatment of osteoporosis in postmenopausal women. It is a deuterated form of bazedoxifene, which means that it contains isotopes of hydrogen (deuterium) that are heavier than normal hydrogen. This modification is intended to improve the stability and pharmacokinetics of the drug.
Bazedoxifene D4 works by binding to estrogen receptors in the body and mimicking the effects of estrogen. This helps to prevent bone loss and reduce the risk of fractures in women with osteoporosis. Unlike estrogen, bazedoxifene D4 does not stimulate the growth of breast tissue or increase the risk of breast cancer.
Chemically, bazedoxifene D4 has a molecular formula of C30H26D4NO4 and a molecular weight of 486.6 g/mol. It is a white to off-white powder that is soluble in ethanol and methanol. Bazedoxifene D4 is typically administered orally in the form of tablets, with a recommended dose of 20 mg per day.
Like all drugs, bazedoxifene D4 may cause side effects such as hot flashes, headaches, and nausea. It may also interact with other medications, so it is important to inform your healthcare provider of any other drugs you are taking. Overall, bazedoxifene D4 is a useful medication for the treatment of osteoporosis in postmenopausal women, and its deuterated form may offer improved therapeutic benefits.
Get an Instant Quote
Related Compounds
Bazedoxifene D4 HCl | Bazedoxifene D4 N oxide | Bazedoxifene D4 Acetate |